The results of this study demonstrated that interactions between Coleus amboinicus compounds and the Glucokinase enzyme were revealed by in silico molecular docking investigations, demonstrating the need for additional research to develop potent glucokinase activators for the treatment of T2DM. The gene discussed is GCK; the disease is type 2 diabetes mellitus.